Sep / 2026

Events Upcoming On site

On site event

Paris Colon Cancer Congress 2026

Table of contents

Overview

Event Highlights

Uniting colorectal cancer specialists, multidisciplinary care teams, researchers, and patient advocates to advance evidence-based and patient-centered care.
Highlighting innovation across early-onset, localized, and metastatic colorectal cancer, including immunotherapy, biomarkers, treatment sequencing, and survivorship.
Giving international experts and patients a platform to share perspectives, debate challenging clinical areas, and improve colorectal cancer outcomes worldwide.

Date / Time

Dec 10, 2026 – Dec 12, 2026

Save to

Google Calendar Outlook Calendar

The Paris Colon Cancer Congress 2026 (P3C) is an international congress dedicated to advancing the multidisciplinary management of colorectal cancer. It will bring together oncologists, surgeons, researchers, healthcare professionals, patient advocates, and leaders to discuss scientific developments and practical challenges in colorectal cancer care.

The programme will address early-onset, localized, and metastatic colorectal cancer, immunotherapy, biomarker-driven treatment, survivorship, quality of life, and multidisciplinary decision-making.

Organized by the Young Oncologist in GI Group – Europe, part of the OncoDaily ecosystem, P3C will provide a platform for international experts and patients to share experience, debate challenging areas, and discuss ways to improve access, communication, and outcomes.

Abstract Submission

Submit Your Abstract

The Paris Colon Cancer Congress 2026 (P3C) is now accepting abstract and clinical case submissions!

P3C 2026 will bring together colorectal cancer specialists, multidisciplinary care teams, researchers, healthcare professionals, patient advocates, and international leaders to exchange knowledge and advance evidence-based, patient-centered colorectal cancer care.

Researchers and healthcare professionals working in colorectal cancer are invited to submit their work and contribute to the scientific programme of P3C 2026.

P3C Merit Travel Grant

Selected high-scoring applicants will be considered for a P3C Merit Travel Grant, providing financial support toward their participation in P3C 2026 in Paris.

Publication Opportunity

Accepted abstracts will be published in the OncoDaily Medical Journal, providing authors with an opportunity to share their work with the global oncology community.

This is your opportunity to:

Present your research or clinical case
Share your work with an international oncology community
Have your accepted abstract published in the OncoDaily Medical Journal
Contribute to important discussions in colorectal cancer care
Connect with experts and colleagues from around the world
Be considered for a P3C Merit Travel Grant

Whether you are an oncologist, physician, resident, fellow, medical student, researcher, or healthcare professional working in colorectal cancer, we invite you to share your work with the P3C community.

Submit your abstract or clinical case and join us in Paris!

🔗 SUBMIT YOUR ABSTRACT OR CLINICAL CASE HERE

Scientific Leadership

Julien Taieb – France

Professor of Gastroenterology and Gastrointestinal Oncology, Université Paris Cité
Head of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, AP-HP

Annalice Gandini – France

Medical Oncologist and Researcher, Hôpital Européen Georges-Pompidou, AP-HP
Researcher, Centre de Recherche des Cordeliers, Université Paris Cité

Amalya Sargsyan – Armenia

Medical Oncologist, Yeolyan Hematology and Oncology Center
Vice President of Research & Intelligence, OncoDaily
Adjunct Assistant Professor, Yerevan State Medical University

Francisco Javier Ros – Spain

Medical Oncologist, Vall d’Hebron University Hospital
Clinical Investigator, Vall d’Hebron Institute of Oncology (VHIO)

Speakers

Images	Name
	Alessandro Pastorino – Italy Medical Oncologist, IRCCS Ospedale Policlinico San Martino Contract Professor, University of Genoa
	Vittorio Studiale – Italy Medical Oncology Resident, University Hospital of Pisa Researcher in Gastrointestinal and Colorectal Oncology
	Lukas Unger – Austria Colorectal Surgeon and Researcher, Medical University of Vienna Specialist in Colorectal Cancer Surgery and Translational Research
	Valentina Daprà – Italy Medical Oncologist, Humanitas Research Hospital Specialist in Gastrointestinal and Colorectal Oncology
	Laura M. Fernandez – Portugal Colorectal Surgeon, Champalimaud Foundation Specialist in Rectal Cancer, Organ Preservation and Watch-and-Wait Strategies
	Raghav Sundar – USA Associate Professor of Medicine, Yale School of Medicine Medical Oncologist specializing in Gastrointestinal Cancers
	Lena Weiss – Germany Medical Oncologist, LMU Klinikum Munich Specialist in Gastrointestinal and Metastatic Colorectal Cancer
	Andrea Pretta – Italy Assistant Professor and Medical Oncologist, University of Cagliari Specialist in Colorectal and Early-Onset Colorectal Cancer
	Elisabeth Bergen – Austria Medical Oncologist, Medical University of Vienna Specialist in Internal Medicine, Hematology and Medical Oncology
	Joan Seoane – Spain Director of Translational Research, Vall d’Hebron Institute of Oncology (VHIO) ICREA Research Professor and Professor at the Autonomous University of Barcelona
	Simon Garinet – France Clinical Molecular Biologist and Assistant Professor, Georges Pompidou European Hospital, AP–HP Université Paris Cité
	Bishal Gyawali – Canada Medical Oncologist and Associate Professor, Queen’s University Scientist, Sinclair Cancer Research Institute
	Joe “Jochen” Lennerz – United States Pathologist and Medical Director of Pathology, BostonGene Associate Professor of Pathology, Harvard Medical School